Haohai Biological Technology updates share capital, confirms buyback activity

As of September 15, 2025, Shanghai Haohai Biological Technology reported its H-share capital remained steady at 38,529,240 shares, with no changes from the August 31, 2025 balance. The A-share capital maintained at 190,203,760 shares, with 3,848,095 treasury A-shares as of the same date. The company's total issued shares (excluding treasury shares) are 228,733,000, comprising 190,203,760 A-shares and 38,529,240 H-shares.

The company repurchased 67,400 A-shares on September 15, 2025, at the Shanghai Stock Exchange. The repurchase prices ranged from HK$27.7 to HK$27.8 per share, totaling HK$1,872,580. These repurchased shares remain uncancelled and are intended for future cancellation, falling under authorization approved on June 10, 2025, which permits buying back up to 3,914,184 shares.

The 67,400 A-shares repurchased represent 0.1722% of the company’s issued share capital (excluding treasury shares) as of the date the repurchase authorization was approved. No new shares are to be issued, nor are treasury shares to be sold or transferred within 30 days following any repurchase activity.